Ignite Creation Date:
2025-12-24 @ 3:38 PM
Ignite Modification Date:
2026-04-16 @ 11:38 AM
Study NCT ID:
NCT00586092
Status:
COMPLETED
Last Update Posted:
2013-04-08
First Post:
2007-12-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tumors
Sponsor:
Herbert Hurwitz
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Pro00008797
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None